Intro

This chapter delves into the recent FDA approval of updated COVID-19 vaccines from Pfizer and Moderna, emphasizing the complexities of vaccine access this fall. The discussion clarifies eligibility limitations, particularly for younger individuals with specific health conditions, while addressing public concerns about access.